Artikel,

Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.

.
Pediatr Rehabil, 6 (2): 85--96 (2003)
DOI: 10.1080/1363849031000139306

Zusammenfassung

A systematic review with the Sachett model of evidence-based medicine of the use of Botulinum toxin type A (BTX) for intervention in children with Cerebral Palsy (CP) is highlighted. Currently, the evidence showed that BTX is useful for treating pes equinus due to spasticity of the gastrocnemius-soleus muscles. However, careful patient selection and goals of treatment have to be addressed. More multi-centre clinical trials with standardized protocols are needed before widespread recommendation of the use of BTX in treating spasticity in CP can be made.

Tags

Nutzer

  • @ar0berts

Kommentare und Rezensionen